Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • WCG CenterWatch iConnect Selected as Patient Recruitment Management System for The Michael J. Fox Foundation’s Clinical Study Matching Tool, Fox Trial Finder

    Mar 3, 2020, 09:15 AM by Michael Croft
    PRINCETON, NJ - Mar 3, 2020 - WCG, the world's leading provider of solutions that measurably improve the quality and efficiency of clinical trials, today announced that The Michael J
    Full story
  • BioIVT Now Provides Same-day Delivery of Fresh Leukopaks and Immune Cell Products in the UK and Overnight to EU Locations

    Mar 3, 2020, 08:13 AM by Michael Croft
    WESTBURY, NY - Mar 3, 2020 - BioIVT, a leading provider of research models and services for drug and diagnostic development, announced that it is now providing same-day delivery of fresh blood, LEUKOMAX® leukopaks and buffy coats from normal and disease-state donors to cell and gene therapy researchers in the UK
    Full story
  • COVID-19 could be identified in minutes via mobile technology

    Mar 2, 2020, 14:04 PM by Michael Croft
    AUCKLAND, NEW ZEALAND - Mar 3, 2020 - Fast testing during viral outbreaks, such as the current COVID-19, could assist to prevent its spread, saving lives and money
    Full story
  • Hints On Data Storage And Transport From High Energy Physics

    Mar 2, 2020, 14:00 PM by Michael Croft

    Bio-IT World | It may be surprising that with a PhD in biochemistry, Brigitte Raumann spends a lot of time these days considering data storage and transport in high energy physics and astronomy. But that also puts her in the perfect position to recognize some of the lessons from those disciplines that the life sciences can pick up.

    Full story
  • Olaris Announces Findings from Exploratory Analysis of Biomarkers that Predict Patient Responsiveness to Trastuzumab Therapy

    Mar 2, 2020, 08:36 AM by Michael Croft
    WALTHAM, MA, UNITED STATES - Mar 2, 2020 - Olaris, a precision medicine company that is working to fundamentally change how diseases are treated, today announced the findings from its exploratory analysis of “biomarkers of response” (BoR) that predict whether a HER2-positive (Her2+) metastatic breast cancer patient will respond to Herceptin® (trastuzumab) therapy
    Full story
  • Solentim names Mark Truesdale as new CEO

    Mar 2, 2020, 04:52 AM by Michael Croft
    BOURNEMOUTH, UK - Mar 2, 2020 - Solentim, the global leader in cell line development instrumentation, today announced that Dr Mark Truesdale has been appointed to the position of CEO
    Full story
  • Legit™ Unveils A New Collaboration Software For Life Sciences

    Feb 28, 2020, 09:55 AM by Michael Croft
    CAMBRIDGE, MA, UNITED STATES - Feb 28, 2020 -  Legit, the leading life sciences collaboration platform, announced today the launch of their new collaboration software geared towards the life sciences
    Full story
  • Alfa Chemistry Introduced Functionalized Nanomaterials

    Feb 27, 2020, 22:16 PM by Michael Croft
    NEW YORK, NY - Feb 28, 2020 - On February 20, 2020, Alfa Chemistry announced to introduce a wide range of functionalized nanomaterials to meet the increasing demand from their global customers
    Full story
  • MGI Announces $100 Genome; Illumina Files Patent Suit

    Feb 27, 2020, 18:25 PM by Michael Croft
    Bio-IT World MGI got some attention with its presentation this week of the $100 genome. Among the feedback, a patent infringement suit from Illumina relating to the “CoolMPS” sequencing products.
    Full story
  • Menarini Silicon Biosystems To Announce New Solutions for Advancing Liquid Biopsy in Clinical Research

    Feb 27, 2020, 12:32 PM by Michael Croft
    BOLOGNA, ITALY AND HUNTINGDON VALLEY, PA - Feb 27, 2020 - Menarini Silicon Biosystems, the pioneer of liquid biopsy and rare cell technologies, announced today that it is developing several new products that could help advance precision medicine research by expanding the capabilities and applications of its CELLSEARCH and DEPArray technologies, for rare cells isolation and single cell analysis
    Full story
  • Illumina, NSA Labs, Certara, And More: News From February 2020

    Feb 27, 2020, 10:10 AM by Michael Croft

    Bio-IT World February featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Illumina, NSA Labs, Certara, and more.

    Full story
  • Bio Filters For Air Pollution Control Outlook, Product, Industry Developments and Opportunities

    Feb 27, 2020, 04:15 AM by Michael Croft
    ALBANY, NY, US - Feb 27, 2020 - Transparency Market Research delivers key insights on the global bio filter market. In terms of revenue, the global bio filter market is estimated to expand at a CAGR of ~7%, based on value, during the forecast period, owing to numerous factors, regarding which, TMR offers thorough insights and forecasts in the global bio filter market report
    Full story
  • The Pistoia Alliance’s Releases Latest Unified Data Model

    Feb 26, 2020, 14:00 PM by Michael Croft
    Bio-IT World  The Pistoia Alliance yesterday released the latest Unified Data Model (UDM) file format, Version 6, supported by funding from Biovia, Elsevier, GSK, Novartis, and Roche (recently joined by BMS). V6 delivers a stable foundation for the collection and exchange of reaction data and empowers the community to move forward with its adoption. The release is built upon standard (Allotrope-compatible) vocabularies for units of measure and analytical methods, allowing the systems to be interoperable. As increased adoption of AI and ML in R&D continues, such industry-wide data standards are essential in the move toward the digitally driven Lab of the Future (LoTF).
    Full story
  • A Deep Look At The Future Of Medicine

    Feb 26, 2020, 13:00 PM by Michael Croft
    Bio-IT World  Cardiologist Eric Topol, author of the Creative Destruction of Medicine and The Patient Will See You Now has often written about medicine and technology. But Deep Medicine isn’t just about technology.
    Full story
  • Stilla Technologies, Yuzi Holdings and TusPark donate digital PCR Naica™ Systems to help fight coronavirus outbreak in China

    Feb 25, 2020, 17:16 PM by Michael Croft
    SAN FRANCISCO BAY AREA, CA, US - Feb 25, 2020 - Paris, February 25, 2020 - Stilla Technologies, a leading provider of pioneering digital PCR (dPCR) solutions for high-precision genetic analyses, just announced it will be joining an initiative led by Yuzi Holdings and TusPark Science & Technology Service Group (TusPark) to donate two Naica Systems to City of Zhengzhou and City of Xinyang[1], in China, to help them better detect the coronavirus and monitor its mutations
    Full story
  • New Players Take the Field: How Private Employer Healthcare Could Mean More Focus on People

    Feb 25, 2020, 12:05 PM by Michael Croft

    Bio-IT World Contributed Commentary | Depending on which side of the gurney you find yourself, the U.S. healthcare system can be simultaneously viewed as either a modern-day gold rush or an impossible financial burden. In large part, this is because humans have been displaced by business objectives as the focal point of healthcare. If you’re seeking some sign of restored equilibrium between massive healthcare corporations (59 of the S&P 500 companies are healthcare-related) and the individuals they are meant to serve, there’s an inkling of real change, growing out of an unlikely corner… other massive corporations. 

    Full story
  • Spring Bank Announces Clinical Collaboration to Evaluate SB 11285 in Combination with PD-L1 Checkpoint Inhibitor in Patients with Advanced Solid Tumors

    Feb 25, 2020, 10:09 AM by Michael Croft
    HOPKINTON, MA, UNITED STATES - Feb 25, 2020 - Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for oncology and inflammatory diseases, today announced a new clinical collaboration with Roche (SIX:RO, ROG), to explore the co-administration of SB 11285, Spring Bank’s intravenously (IV)-administered STING (STimulator of INterferon Gene) agonist with Roche’s PD-L1 checkpoint inhibitor atezolizumab (Tecentriq®) in patients with advanced solid tumors
    Full story
  • The Pistoia Alliance’s UDM Project Reaches Major Milestone

    Feb 25, 2020, 09:15 AM by Michael Croft
    BOSTON, MA, UNITED STATES - Feb 25, 2020 - The Pistoia Alliance, a global, not-for-profit alliance that works to lower barriers to innovation in life sciences R&D, today released the latest Unified Data Model (UDM) file format, Version 6, supported by funding from Biovia, Elsevier, GSK, Novartis, and Roche (recently joined by BMS)
    Full story
  • Certara’s Simcyp Division Acquires Modeling and Simulation Platform for Neurodegenerative Diseases from In Silico Biosciences, Inc.

    Feb 25, 2020, 08:36 AM by Michael Croft
    PRINCETON, NJ - Feb 25, 2020 - Certara®, the global model-informed drug development and decision support leader, today reported that it has acquired a range of modeling and simulation technology assets from In Silico Biosciences, Inc
    Full story
  • LUNAC Therapeutics selects Domainex as its strategic drug discovery partner

    Feb 25, 2020, 04:50 AM by Michael Croft
    CAMBRIDGE AND LEEDS, UNITED KINGDOM - Feb 25, 2020 - Domainex Ltd., a fully integrated provider of drug discovery services from its Medicines Research Centre near Cambridge, UK, has entered into a research partnership with LUNAC Therapeutics Limited to discover novel anticoagulant therapies  that have a reduced risk of bleeding compared to current therapies
    Full story
  • «
  • 211 (current)
  • 212
  • 213
  • 214
  • 215
  • 216
  • 217
  • 218
  • 219
  • 220
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy